HERBALIFE LTD (HLF) Fundamental Analysis & Valuation

NYSE:HLF • KYG4412G1010

Current stock price

16.77 USD
-0.21 (-1.24%)
Last:

This HLF fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. HLF Profitability Analysis

1.1 Basic Checks

  • HLF had positive earnings in the past year.
  • In the past year HLF had a positive cash flow from operations.
  • HLF had positive earnings in each of the past 5 years.
  • Each year in the past 5 years HLF had a positive operating cash flow.
HLF Yearly Net Income VS EBIT VS OCF VS FCFHLF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

1.2 Ratios

  • With a decent Return On Assets value of 8.19%, HLF is doing good in the industry, outperforming 72.97% of the companies in the same industry.
Industry RankSector Rank
ROA 8.19%
ROE N/A
ROIC N/A
ROA(3y)7.53%
ROA(5y)10.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HLF Yearly ROA, ROE, ROICHLF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

1.3 Margins

  • HLF has a Profit Margin of 4.53%. This is in the better half of the industry: HLF outperforms 67.57% of its industry peers.
  • HLF's Profit Margin has declined in the last couple of years.
  • HLF's Operating Margin has declined in the last couple of years.
  • The Gross Margin of HLF (77.87%) is better than 89.19% of its industry peers.
  • HLF's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 4.53%
GM 77.87%
OM growth 3Y-3.15%
OM growth 5Y-3.06%
PM growth 3Y-9.79%
PM growth 5Y-7.59%
GM growth 3Y0.18%
GM growth 5Y-0.35%
HLF Yearly Profit, Operating, Gross MarginsHLF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

2

2. HLF Health Analysis

2.1 Basic Checks

  • HLF does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for HLF has been increased compared to 1 year ago.
  • The number of shares outstanding for HLF has been reduced compared to 5 years ago.
  • HLF has a better debt/assets ratio than last year.
HLF Yearly Shares OutstandingHLF Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
HLF Yearly Total Debt VS Total AssetsHLF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • HLF has an Altman-Z score of 1.17. This is a bad value and indicates that HLF is not financially healthy and even has some risk of bankruptcy.
  • HLF has a Altman-Z score (1.17) which is in line with its industry peers.
  • HLF has a debt to FCF ratio of 7.88. This is a slightly negative value and a sign of low solvency as HLF would need 7.88 years to pay back of all of its debts.
  • HLF has a Debt to FCF ratio (7.88) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.88
Altman-Z 1.17
ROIC/WACCN/A
WACC9.94%
HLF Yearly LT Debt VS Equity VS FCFHLF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

2.3 Liquidity

  • A Current Ratio of 1.13 indicates that HLF should not have too much problems paying its short term obligations.
  • HLF has a worse Current ratio (1.13) than 72.97% of its industry peers.
  • HLF has a Quick Ratio of 1.13. This is a bad value and indicates that HLF is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.62, HLF is not doing good in the industry: 75.68% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.62
HLF Yearly Current Assets VS Current LiabilitesHLF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. HLF Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 8.67% over the past year.
  • HLF shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.16% yearly.
  • The Revenue has been growing slightly by 0.89% in the past year.
  • The Revenue has been decreasing by -1.89% on average over the past years.
EPS 1Y (TTM)8.67%
EPS 3Y-14.35%
EPS 5Y-10.16%
EPS Q2Q%25%
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-1.08%
Revenue growth 5Y-1.89%
Sales Q2Q%6.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.82% on average over the next years. This is quite good.
  • Based on estimates for the next years, HLF will show a small growth in Revenue. The Revenue will grow by 4.27% on average per year.
EPS Next Y20.74%
EPS Next 2Y17.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.73%
Revenue Next 2Y4.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HLF Yearly Revenue VS EstimatesHLF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
HLF Yearly EPS VS EstimatesHLF Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

8

4. HLF Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 7.87, the valuation of HLF can be described as very cheap.
  • 91.89% of the companies in the same industry are more expensive than HLF, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of HLF to the average of the S&P500 Index (27.95), we can say HLF is valued rather cheaply.
  • The Price/Forward Earnings ratio is 6.52, which indicates a rather cheap valuation of HLF.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HLF indicates a rather cheap valuation: HLF is cheaper than 91.89% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 38.68. HLF is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.87
Fwd PE 6.52
HLF Price Earnings VS Forward Price EarningsHLF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, HLF is valued cheaply inside the industry as 94.59% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.86
EV/EBITDA N/A
HLF Per share dataHLF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • HLF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as HLF's earnings are expected to grow with 17.82% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y17.82%
EPS Next 3YN/A

0

5. HLF Dividend Analysis

5.1 Amount

  • HLF does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HLF Fundamentals: All Metrics, Ratios and Statistics

HERBALIFE LTD

NYSE:HLF (4/21/2026, 10:37:46 AM)

16.77

-0.21 (-1.24%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-18
Earnings (Next)05-06
Inst Owners102.23%
Inst Owner Change-0.08%
Ins Owners5.23%
Ins Owner Change0.81%
Market Cap1.73B
Revenue(TTM)5.04B
Net Income(TTM)228.30M
Analysts77.78
Price Target17.85 (6.44%)
Short Float %8.03%
Short Ratio4.95
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.93%
Min EPS beat(2)4.47%
Max EPS beat(2)7.39%
EPS beat(4)4
Avg EPS beat(4)30.94%
Min EPS beat(4)4.47%
Max EPS beat(4)59.17%
EPS beat(8)8
Avg EPS beat(8)40.78%
EPS beat(12)9
Avg EPS beat(12)22.69%
EPS beat(16)13
Avg EPS beat(16)25.36%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)2.07%
Revenue beat(4)1
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)2.07%
Revenue beat(8)2
Avg Revenue beat(8)-0.99%
Revenue beat(12)6
Avg Revenue beat(12)-0.06%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)2.94%
PT rev (3m)20.69%
EPS NQ rev (1m)4.21%
EPS NQ rev (3m)-10.15%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.26%
Revenue NQ rev (1m)1.16%
Revenue NQ rev (3m)2.6%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)1.71%
Valuation
Industry RankSector Rank
PE 7.87
Fwd PE 6.52
P/S 0.34
P/FCF 6.86
P/OCF 5.2
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)2.13
EY12.7%
EPS(NY)2.57
Fwd EY15.34%
FCF(TTM)2.45
FCFY14.58%
OCF(TTM)3.22
OCFY19.22%
SpS48.71
BVpS-4.98
TBVpS-9
PEG (NY)0.38
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 8.19%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.53%
GM 77.87%
FCFM 5.02%
ROA(3y)7.53%
ROA(5y)10.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)29.25%
ROCE(5y)32.45%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.15%
OM growth 5Y-3.06%
PM growth 3Y-9.79%
PM growth 5Y-7.59%
GM growth 3Y0.18%
GM growth 5Y-0.35%
F-Score6
Asset Turnover1.81
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 7.88
Debt/EBITDA N/A
Cap/Depr 66.34%
Cap/Sales 1.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 110.78%
Current Ratio 1.13
Quick Ratio 0.62
Altman-Z 1.17
F-Score6
WACC9.94%
ROIC/WACCN/A
Cap/Depr(3y)95.33%
Cap/Depr(5y)112.44%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.46%
Profit Quality(3y)110.5%
Profit Quality(5y)92.32%
High Growth Momentum
Growth
EPS 1Y (TTM)8.67%
EPS 3Y-14.35%
EPS 5Y-10.16%
EPS Q2Q%25%
EPS Next Y20.74%
EPS Next 2Y17.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-1.08%
Revenue growth 5Y-1.89%
Sales Q2Q%6.26%
Revenue Next Year4.73%
Revenue Next 2Y4.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-231.85%
EBIT growth 3Y-4.2%
EBIT growth 5Y-4.89%
EBIT Next Year36.7%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.77%
FCF growth 3Y8.85%
FCF growth 5Y-13.31%
OCF growth 1Y16.78%
OCF growth 3Y-1.85%
OCF growth 5Y-11.92%

HERBALIFE LTD / HLF Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HERBALIFE LTD?

ChartMill assigns a fundamental rating of 4 / 10 to HLF.


What is the valuation status for HLF stock?

ChartMill assigns a valuation rating of 8 / 10 to HERBALIFE LTD (HLF). This can be considered as Undervalued.


Can you provide the profitability details for HERBALIFE LTD?

HERBALIFE LTD (HLF) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for HLF stock?

The Price/Earnings (PE) ratio for HERBALIFE LTD (HLF) is 7.87 and the Price/Book (PB) ratio is -3.37.


How financially healthy is HERBALIFE LTD?

The financial health rating of HERBALIFE LTD (HLF) is 2 / 10.